March 18, 2022Open Access

Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

In regions (like Ontario) where PCP is rare, routine PCP prophylaxis with trimethoprim-sulfamethoxazole should not be offered, since the harms may outweigh the benefits.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Climans et al. (Fri,) studied this question.

synapsesocial.com/papers/69d91dec8988aeabbe6842c4 https://doi.org/https://doi.org/10.1093/neuonc/noac072

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Odds Ratio, Relative Risk, Absolute Risk Reduction, and the Number Needed to Treat—Which of These Should We Use?2002 · 215 citations
2Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors2003 · 72 citations
3An application of capture-recapture methods to the estimation of completeness of cancer registration1988 · 584 citations
4Neuro‐oncology practices in <scp>A</scp>ustralia: A Cooperative Group for Neuro‐Oncology patterns of care study2013 · 16 citations
5<i>Pneumocystis carinii</i> and Geographic Clustering2000 · 12 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo